Pyridine matrix metalloproteinase inhibitors
US7015237B2 · kind B2 · utility
6Cited by
14References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2004 |
| Grant date | Mar 21, 2006 |
| Priority date | — |
| Expiry date | May 10, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Selective MMP-13 inhibitors are pyridine derivatives of the formula or a pharmaceutically acceptable salt thereof,wherein:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.